Fact CheckerSign in

NCT07420907Recruiting

Study of the Progression of Chronic Cardiovascular Conditions

A Non-interventional Observational Study of the Sustained Use of Prolaio Digital Health Devices to Monitor the Natural History of Chronic Cardiovascular Conditions in Ambulatory Patients

Source: ClinicalTrials.gov · Last updated 12 Aug 2026

Brief summary (registry, in English)

This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.

Status (registry)
Recruiting
Study type
Observational
Enrollment
5000 (estimated)
First submitted
2 Dec 2025
Start date
30 Oct 2025
Primary completion date
31 Oct 2030
Lead sponsor
Prolaio
NCT number
NCT07420907

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 30 Oct 2025 to the primary completion date, 31 Oct 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Allergy to adhesive used in biosensor patch
  • Life-threatening disease process outside of area under study, such as actively treated cancer or being actively considered for organ pre-transplant (such as hepatic failure; end-stage renal disease).
  • Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV

Other

  • \-- For participants who do not qualify due to this exclusion, and have not been hospitalized within 30 days of enrollment, they may reapply to enroll in the study
  • Self-reported weight of 400 pounds or greater

Who the study is looking for

  • 18 years of age and older
  • Ability to understand study assessments and give informed consent to data collection
  • Ability to comply with the study protocol
  • Ability to understand and respond to instructions in English
  • Has diagnosis of qualifying Cardiovascular Disease(s), including but not limited to: HF, AS, HCM, HTN, DCM, etc. Additional CVD may be included at discretion of the investigators.
  • Resides in the United States

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prolaio
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.